Corteva, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

21,200 Shares in Corteva, Inc. $CTVA Bought by iSAM Funds UK Ltd - marketbeat.com

AI-generated analysis

πŸ“ˆ Corteva reported Q2 EPS of $2.30, beating the $2.24 consensus estimate despite revenue falling 1.2% to $6.38 billion.

🏦 iSAM Funds UK Ltd acquired 21,200 shares worth $1.795 million, making Corteva its 10th-largest holding at 1.3% of the portfolio.

πŸ“Š Institutional investors collectively own 81.54% of the company's outstanding stock.

πŸ’° The company declared a quarterly dividend of $0.18 per share with an annualized yield of 0.8% and a payout ratio of 47.68%.

πŸ“ˆ Analysts maintain a consensus 'Moderate Buy' rating with an average price target of $91.50.

πŸ” Oppenheimer upgraded its price target to $95.00 and issued an 'outperform' rating on Thursday, July 23rd.

πŸ“ˆ Jefferies Financial Group boosted its price target from $95.00 to $97.00 in a research note.

πŸ“ˆ Morgan Stanley raised its price target to $95.00 and assigned an 'overweight' rating.

πŸ“ˆ Deutsche Bank reiterated a 'buy' rating with a new price target of $101.00.

πŸ“ˆ Barclays raised its price target from $84.00 to $91.00 and maintained an 'overweight' rating.

πŸ“‰ Corteva's stock has a 52-week high of $90.97 and a low of $60.53, currently trading near the upper end of its range.

🏒 The company operates as an independent global agriculture firm focusing on seed genetics, crop protection chemistries, and digital tools.

Bullish Signals
  • Corteva beat Q2 earnings expectations with EPS of $2.30 versus the $2.24 consensus estimate.
  • Institutional ownership remains robust at 81.54%, with iSAM Funds UK Ltd adding a new stake of 21,200 shares.
  • Multiple analysts recently upgraded price targets, including Oppenheimer to $95.00, Jefferies to $97.00, and Morgan Stanley to $95.00.
  • The company declared a quarterly dividend of $0.18 per share with an annualized yield of 0.8%.
  • Deutsche Bank reiterated a 'buy' rating and issued a higher price target of $101.00.
Risk Factors
  • Q2 revenue fell 1.2% year-over-year to $6.38 billion, missing analyst estimates of $6.60 billion.
  • The stock trades at a high price-to-earnings ratio of 59.65 relative to its growth profile.
Full Analysis
Corteva, Inc. (CTVA) reported second-quarter earnings that beat analyst expectations for EPS at $2.30 versus the $2.24 consensus, though revenue declined 1.2% year-over-year to $6.38 billion, missing estimates of $6.60 billion. The company maintains a net margin of 5.66% and a return on equity of 10.18%, with analysts projecting FY 2026 EPS between $3.60 and $3.80. Institutional ownership remains strong at 81.54%, highlighted by iSAM Funds UK Ltd acquiring 21,200 shares worth approximately $1.795 million in the second quarter to make Corteva its 10th-largest holding. Several other institutional investors, including William B. Walkup & Associates Inc., Wilkerson Advisory Group LLC, and First Horizon Corp, increased their stakes during the first quarter. Wall Street analysts maintain a favorable outlook with a consensus 'Moderate Buy' rating and an average price target of $91.50. Recent upgrades include Oppenheimer raising its target to $95.00, Jefferies Financial Group boosting it to $97.00, and Morgan Stanley increasing its target to $95.00 with an 'overweight' rating. Corteva declared a quarterly dividend of $0.18 per share, payable on September 15th to shareholders of record on September 1st, representing a 0.8% annualized yield and a payout ratio of 47.68%. The stock currently trades at a market capitalization of $60.09 billion with a price-to-earnings ratio of 59.65.